Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria

Journal of Microbiological Methods

Volumn 91, Issue 2, 2012, Pages 222-230

  Frohlich, Kyla ^a   Hua, Ziyu ^b   Wang, Jin ^a   Shen, Li ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Chlamydia trachomatis; Intracellular bacterial infection; Membrane vesicles

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPICILLIN; OUTER MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; PURIFICATION;

ANIMALS; BLOTTING, WESTERN; CELL FRACTIONATION; CELL LINE, TUMOR; CELL MEMBRANE; CENTRIFUGATION; CHLAMYDIA TRACHOMATIS; CHROMATOGRAPHY, AFFINITY; CYTOPLASM; FIBROBLASTS; MICE; MICROSCOPY, ELECTRON; SECRETORY VESICLES;

EID: 84867777628     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.08.012     Document Type: Article

References (56)

1. Andersen S.R., Bjune G., Hoiby E.A., Michaelsen T.E., Aase A., Rye U., Jantzen E. Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response. Vaccine 1997, 15:1225-1234.
2. Arigita C., Luijkx T., Jiskoot W., Poelen M., Hennink W.E., Crommelin D.J., Ley P., Els C., Kersten G.F. Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives. Vaccine 2005, 23:5091-5098.
3. Beatty W.L. Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J. Cell Sci. 2006, 119:350-359.
4. Beatty W.L., Morrison R.P., Byrne G.I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 1994, 58:686-699.
5. Belland R.J., Scidmore M.A., Crane D.D., Hogan D.M., Whitmire W., McClarty G., Caldwell H.D. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13984-13989.
6. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 2005, 5:149-161.
7. Carabeo R.A., Grieshaber S.S., Fischer E., Hackstadt T. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect. Immun. 2002, 70:3793-3803.
8. Carlson J.H., Porcella S.F., McClarty G., Caldwell H.D. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 2005, 73:6407-6418.
9. Chen D., Lei L., Lu C., Galaleldeen A., Hart P.J., Zhong G. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J. Bacteriol. 2010, 192:6017-6024.
10. Clifton D.R., Fields K.A., Grieshaber S.S., Dooley C.A., Fischer E.R., Mead D.J., Carabeo R.A., Hackstadt T. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10166-10171.
11. Deatherage B.L., Cookson B.T. Membrane vesicle release in Bacteria, Eukaryotes and Archaea: a conserved yet underappreciated aspect of microbial life. Infect. Immun. 2012, 80:1948-1957.
12. Elwell C.A., Jiang S., Kim J.H., Lee A., Wittmann T., Hanada K., Melancon P., Engel J.N. Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development. PLoS Pathog. 2011, 7:e1002198.
13. Fields K.A., Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 2002, 18:221-245.
14. Garrity G.M. Bergey's Manual of Systematic Bacteriology 2010, Springer, New York.
15. Gerard H.C., Freise J., Wang Z., Roberts G., Rudy D., Krauss-Opatz B., Kohler L., Zeidler H., Schumacher H.R., Whittum-Hudson J.A., Hudson A.P. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect. 2002, 4:13-22.
16. Giles D.K., Wyrick P.B. Trafficking of chlamydial antigens to the endoplasmic reticulum of infected epithelial cells. Microbes Infect. 2008, 10:1494-1503.
17. Giles D.K., Whittimore J.D., LaRue R.W., Raulston J.E., Wyrick P.B. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. Microbes Infect. 2006, 8:1579-1591.
18. Gottlieb R.A., Adachi S. Nitrogen cavitation for cell disruption to obtain mitochondria from cultured cells. Methods Enzymol. 2000, 322:213-221.
19. Hackstadt T., Scidmore M.A., Rockey D.D. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4877-4881.
20. Hackstadt T., Rockey D.D., Heinzen R.A., Scidmore M.A. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 1996, 15:964-977.
21. Hatch T.P. Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae?. J. Bacteriol. 1996, 178:1-5.
22. Hatch T.P. Developmental Biology. Chlamydia. Intracellular Biology. Pathogenesis, and Immunity 1999, 29-67. American Society for Microbiology, Washington, DC. R.S. Stephens (Ed.).
23. Hatch T.P., Al-Hossainy E., Silverman J.A. Adenine nucleotide and lysine transport in Chlamydia psittaci. J. Bacteriol. 1982, 150:662-670.
24. Herrera V.L., Shen L., Lopez L.V., Didishvili T., Zhang Y.X., Ruiz-Opazo N. Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model. Mol. Med. 2003, 9:135-142.
25. Hogan R.J., Mathews S.A., Mukhopadhyay S., Summersgill J.T., Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect. Immun. 2004, 72:1843-1855.
26. Hua Z., Rao X., Feng X., Luo X., Liang Y., Shen L. Mutagenesis of region 4 of sigma 28 from Chlamydia trachomatis defines determinants for protein-protein and protein-DNA interactions. J. Bacteriol. 2009, 191:651-660.
27. Kellogg K.R., Horoschak K.D., Moulder J.W. Toxicity of low and moderate multiplicities of Chlamydia psittici for mouse fibroblasts (L cells). Infect. Immun. 1977, 18:531-541.
28. Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 2010, 64:163-184.
29. Kumar Y., Valdivia R.H. Reorganization of the host cytoskeleton by the intracellular pathogen Chlamydia trachomatis. Commun. Integr. Biol. 2008, 1:175-177.
30. Lambden P.R., Pickett M.A., Clarke I.N. The effect of penicillin on Chlamydia trachomatis DNA replication. Microbiology 2006, 152:2573-2578.
31. Li Z., Chen D., Zhong Y., Wang S., Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect. Immun. 2008, 76:3415-3428.
32. Matsumoto A., Manire G.P. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 1970, 101:278-285.
33. Moulder J.W. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 1991, 55:143-190.
34. Moulder J.W., Hatch T.P., Byrne G.I., Kellogg K.R. Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells). Infect. Immun. 1976, 14:277-289.
35. Muralinath M., Kuehn M.J., Roland K.L., Curtiss R. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect. Immun. 2011, 79:887-894.
36. Nieves W., Asakrah S., Qazi O., Brown K.A., Kurtz J., Aucoin D.P., McLachlan J.B., Roy C.J., Morici L.A. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 2011, 29:8381-8389.
37. Pokrovskaya I.D., Szwedo J.W., Goodwin A., Lupashina T.V., Nagarajan U.M., Lupashin V.V. Chlamydia trachomatis hijacks intra-Golgi COG complex-dependent vesicle trafficking pathway. Cell. Microbiol. 2012, 14:656-668.
38. Ramsey K.H., Sigar I.M., Schripsema J.H., Denman C.J., Bowlin A.K., Myers G.A., Rank R.G. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect. Immun. 2009, 77:3284-3293.
39. Sanchez S., Troncoso G., Ferreiros C.M., Criado M.T. Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria. Vaccine 2001, 19:3390-3398.
40. Schachter J., Wyrick P.B. Culture and isolation of Chlamydia trachomatis. Methods Enzymol. 1994, 236:377-390.
41. Scidmore M.A. Cultivation and laboratory maintenance of Chlamydia trachomatis. Curr. Protoc. Microbiol. 2005, (Chapter 11, Unit 11A 11).
42. Su E.L., Snape M.D. A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. Expert Rev. Vaccines 2011, 10:575-588.
43. Subtil A. Rerouting of host lipids by bacteria: are you CERTain you need a vesicle?. PLoS Pathog. 2011, 7:e1002208.
44. Sun G., Pal S., Sarcon A.K., Kim S., Sugawara E., Nikaido H., Cocco M.J., Peterson E.M., De la Maza L.M. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J. Bacteriol. 2007, 189:6222-6235.
45. Swanson A.F., Kuo C.C. Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect. Immun. 1994, 62:24-28.
46. Tamura A., Matsumoto A., Manire G.P., Higashi N. Electron microscopic observations on the structure of the envelopes of mature elementary bodies and developmental reticulate forms of Chlamydia psittaci. J. Bacteriol. 1971, 105:355-360.
47. Thalmann J., Janik K., May M., Sommer K., Ebeling J., Hofmann F., Genth H., Klos A. Actin re-organization induced by Chlamydia trachomatis serovar D-evidence for a critical role of the effector protein CT166 targeting Rac. PLoS One 2010, 5:e9887.
48. Tjaden J., Winkler H.H., Schwoppe C., Van Der Laan M., Mohlmann T., Neuhaus H.E. Two nucleotide transport proteins in Chlamydia trachomatis, one for net nucleoside triphosphate uptake and the other for transport of energy. J. Bacteriol. 1999, 181:1196-1202.
49. Van Ooij C., Apodaca G., Engel J. Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect. Immun. 1997, 65:758-766.
50. Van Ooij C., Kalman L., Van I., Nishijima M., Hanada K., Mostov K., Engel J.N. Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell. Microbiol. 2000, 2:627-637.
51. Wang Y., Berg E.A., Feng X., Shen L., Smith T., Costello C.E., Zhang Y.X. Identification of surface-exposed components of MOMP of Chlamydia trachomatis serovar F. Protein Sci. 2006, 15:122-134.
52. Wang J., Frohlich K.M., Buckner L., Quayle A.J., Luo M., Feng X., Beatty W., Hua Z., Rao X., Lewis M.E., Sorrells K., Santiago K., Zhong G., Shen L. Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Microbiology 2011, 157:2759-2771.
53. Winkler H.H. Rickettsial permeability. An ADP-ATP transport system. J. Biol. Chem. 1976, 251:389-396.
54. Wyrick P.B. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 2010, 201(Suppl. 2):S88-S95.
55. Zhang Y.X., Watkins N.G., Stewart S., Caldwell H.D. The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes. Infect. Immun. 1987, 55:2570-2573.
56. Zhong G., Fan P., Ji H., Dong F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 2001, 193:935-942.